Population pharmacokinetic modeling of asciminib in support of exposure-response and ethnic sensitivity analyses in patients with chronic myeloid leukemia.
Saved in:
| Title: | Population pharmacokinetic modeling of asciminib in support of exposure-response and ethnic sensitivity analyses in patients with chronic myeloid leukemia. |
|---|---|
| Authors: | Darstein C; Novartis Pharma AG, Basel, Switzerland., Yoon D; Novartis Pharmaceuticals Corporation, Cambridge, MA, USA., Yang Y; Novartis Pharmaceuticals Corporation, Cambridge, MA, USA., Kapoor S; Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, New Jersey, 07936-1080, USA., Dasgupta K; Novartis Healthcare Private Ltd, Hyderabad, India., Wu S; Novartis Institutes for BioMedical Research Co. Ltd, Shanghai, China., Kawakita Y; Novartis Pharma K.K, Tokyo, Japan., Hoch M; Novartis Pharma AG, Basel, Switzerland., Grosch K; Novartis Pharma AG, Basel, Switzerland., Sy SKB; Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, New Jersey, 07936-1080, USA. sherwin.sy@novartis.com. |
| Source: | Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2025 Feb 28; Vol. 95 (1), pp. 39. Date of Electronic Publication: 2025 Feb 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-0843 |
|---|---|
| DOI: | 10.1007/s00280-025-04755-y |
